Spots Global Cancer Trial Database for Analysis of a New Biomarker for Prostate Cancer Diagnosis
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Analysis of a New Biomarker for Prostate Cancer Diagnosis
Official Title:
Study ID: NCT01819740
Conditions
Study Description
Brief Summary: The aim of our study is to determine if the levels of the "HEM" substance in seminal plasma are associated with the presence of prostate cancer in transrectal prostate biopsy.
Detailed Description:
Keywords
Eligibility
Minimum Age: 45 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: MALE
Healthy Volunteers: No
Locations
Hospital Universitario Parc Taulí, Sabadell, Barcelona, Spain
Contact Details
Name: Miriam Barrio-Muñoz
Affiliation: Hospital Universitario Parc Tauli de Sabadell. Spain
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
